chr12-132664381-G-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_006231.4(POLE):​c.2550C>T​(p.Ile850Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00265 in 1,613,584 control chromosomes in the GnomAD database, including 107 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. I850I) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.014 ( 57 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 50 hom. )

Consequence

POLE
NM_006231.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:17

Conservation

PhyloP100: -2.92

Publications

3 publications found
Variant links:
Genes affected
POLE (HGNC:9177): (DNA polymerase epsilon, catalytic subunit) This gene encodes the catalytic subunit of DNA polymerase epsilon. The enzyme is involved in DNA repair and chromosomal DNA replication. Mutations in this gene have been associated with colorectal cancer 12 and facial dysmorphism, immunodeficiency, livedo, and short stature. [provided by RefSeq, Sep 2013]
POLE Gene-Disease associations (from GenCC):
  • POLE-related polyposis and colorectal cancer syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • colorectal cancer, susceptibility to, 12
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • facial dysmorphism-immunodeficiency-livedo-short stature syndrome
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • IMAGe syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Polymerase proofreading-related adenomatous polyposis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 12-132664381-G-A is Benign according to our data. Variant chr12-132664381-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 221167.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.92 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0139 (2108/152146) while in subpopulation AFR AF = 0.0472 (1956/41472). AF 95% confidence interval is 0.0454. There are 57 homozygotes in GnomAd4. There are 995 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 57 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006231.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POLE
NM_006231.4
MANE Select
c.2550C>Tp.Ile850Ile
synonymous
Exon 22 of 49NP_006222.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POLE
ENST00000320574.10
TSL:1 MANE Select
c.2550C>Tp.Ile850Ile
synonymous
Exon 22 of 49ENSP00000322570.5
POLE
ENST00000535270.5
TSL:1
c.2469C>Tp.Ile823Ile
synonymous
Exon 21 of 48ENSP00000445753.1
POLE
ENST00000537064.5
TSL:1
n.*1597C>T
non_coding_transcript_exon
Exon 22 of 49ENSP00000442578.1

Frequencies

GnomAD3 genomes
AF:
0.0138
AC:
2105
AN:
152028
Hom.:
57
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0472
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00635
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000279
Gnomad OTH
AF:
0.0153
GnomAD2 exomes
AF:
0.00357
AC:
898
AN:
251280
AF XY:
0.00275
show subpopulations
Gnomad AFR exome
AF:
0.0458
Gnomad AMR exome
AF:
0.00307
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000273
Gnomad OTH exome
AF:
0.00244
GnomAD4 exome
AF:
0.00149
AC:
2176
AN:
1461438
Hom.:
50
Cov.:
32
AF XY:
0.00130
AC XY:
948
AN XY:
727062
show subpopulations
African (AFR)
AF:
0.0472
AC:
1578
AN:
33464
American (AMR)
AF:
0.00311
AC:
139
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000128
AC:
11
AN:
86252
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53228
Middle Eastern (MID)
AF:
0.00607
AC:
35
AN:
5768
European-Non Finnish (NFE)
AF:
0.000199
AC:
221
AN:
1111786
Other (OTH)
AF:
0.00318
AC:
192
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
125
251
376
502
627
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0139
AC:
2108
AN:
152146
Hom.:
57
Cov.:
32
AF XY:
0.0134
AC XY:
995
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.0472
AC:
1956
AN:
41472
American (AMR)
AF:
0.00634
AC:
97
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5162
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000279
AC:
19
AN:
68008
Other (OTH)
AF:
0.0152
AC:
32
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
100
200
300
400
500
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00457
Hom.:
7
Bravo
AF:
0.0155
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.000382
EpiControl
AF:
0.000415

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
5
not provided (5)
-
-
2
Colorectal cancer, susceptibility to, 12 (2)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
1
Colorectal cancer, susceptibility to, 12;C3554576:Facial dysmorphism-immunodeficiency-livedo-short stature syndrome;C5193036:Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency (1)
-
-
1
Polymerase proofreading-related adenomatous polyposis;C3896578:Familial colorectal cancer type X (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
0.093
DANN
Benign
0.77
PhyloP100
-2.9
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5744834; hg19: chr12-133240967; API